Cancer is a multifaceted global health issue and one of the leading causes of death
worldwide. In recent years, medical science has achieved great advances in the diagnosis …

Lung cancer (LC) is one of the leading causes of mortality accounting for almost 25% of
cancer deaths throughout the world. The shortfall of affordable and effective first-line …

Despite the critical breakthrough achieved by immune checkpoint blockade (ICB), the
clinical benefits are usually restricted by inefficient infiltration of immune cells and immune …

Over the past decade, the growing interest in targeted lung cancer therapy has guided
researchers toward the cutting edge of controlled drug delivery, particularly magnetic …

Liquid crystals (LCs) possess unique physicochemical properties, translatable into a wide
range of applications. To date, lipidic lyotropic LCs (LLCs) have been extensively explored …

Drug repurposing or repositioning has been well-known to refer to the therapeutic
applications of a drug for another indication other than it was originally approved for …

Lung cancer has the highest death rate among cancers globally. Hepcidin is a fascinating
regulator of iron metabolism; however, the prognostic value of hepcidin and its correlation …

Highlights•AMPs can selectively target and destroy cancer cells but not healthy cells.•AMPs
exhibit minimal systemic toxicity and minimal chance for acquiring resistance.•NSCLC cells …

Non-small cell lung cancer (NSCLC) is a global disorder, treatment options for which remain
limited with resistance development by cancer cells and off-target events being major …

The advancement of message RNA (mRNA)‐based immunotherapies for cancer is highly
dependent on the effective delivery of RNA (Ribonucleic) payloads using ionizable lipid …